VLG Stock Overview
Develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Venture Life Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.39 |
| 52 Week High | UK£0.43 |
| 52 Week Low | UK£0.27 |
| Beta | 0.24 |
| 1 Month Change | 1.30% |
| 3 Month Change | 9.09% |
| 1 Year Change | -3.70% |
| 3 Year Change | -57.14% |
| 5 Year Change | -17.89% |
| Change since IPO | -63.72% |
Recent News & Updates
Venture Life Group plc (LON:VLG) Screens Well But There Might Be A Catch
Feb 02
Venture Life Group (LON:VLG) Has A Somewhat Strained Balance Sheet
Nov 23Recent updates
Venture Life Group plc (LON:VLG) Screens Well But There Might Be A Catch
Feb 02Venture Life Group (LON:VLG) Has A Somewhat Strained Balance Sheet
Nov 23Venture Life Group plc's (LON:VLG) Intrinsic Value Is Potentially 75% Above Its Share Price
Sep 01Does Venture Life Group (LON:VLG) Deserve A Spot On Your Watchlist?
Mar 11Here's Why Venture Life Group (LON:VLG) Has A Meaningful Debt Burden
Nov 18Is Venture Life Group (LON:VLG) A Risky Investment?
May 25An Intrinsic Calculation For Venture Life Group plc (LON:VLG) Suggests It's 48% Undervalued
Dec 02Venture Life Group plc (LON:VLG) Analysts Just Slashed This Year's Revenue Estimates By 10%
Dec 02Venture Life Group (LON:VLG) Has A Somewhat Strained Balance Sheet
Oct 30Here's Why Shareholders Will Not Be Complaining About Venture Life Group plc's (LON:VLG) CEO Pay Packet
May 14Venture Life Group (LON:VLG) Could Easily Take On More Debt
Mar 30Could The Venture Life Group plc (LON:VLG) Ownership Structure Tell Us Something Useful?
Feb 10If You Like EPS Growth Then Check Out Venture Life Group (LON:VLG) Before It's Too Late
Jan 20Here's Why We Don't Think Venture Life Group's (LON:VLG) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 30The Venture Life Group (LON:VLG) Share Price Is Up 213% And Shareholders Are Boasting About It
Dec 11
The Chief Manufacturing Officer & Executive Director of Venture Life Group plc (LON:VLG), Lodovico Braguti, Just Sold 74% Of Their Holding
Nov 25Do Its Financials Have Any Role To Play In Driving Venture Life Group plc's (LON:VLG) Stock Up Recently?
Nov 17Shareholder Returns
| VLG | GB Personal Products | GB Market | |
|---|---|---|---|
| 7D | -3.7% | -0.4% | -0.6% |
| 1Y | -3.7% | 1.7% | 7.7% |
Return vs Industry: VLG underperformed the UK Personal Products industry which returned 0.7% over the past year.
Return vs Market: VLG underperformed the UK Market which returned 6.5% over the past year.
Price Volatility
| VLG volatility | |
|---|---|
| VLG Average Weekly Movement | 4.8% |
| Personal Products Industry Average Movement | 4.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: VLG has not had significant price volatility in the past 3 months.
Volatility Over Time: VLG's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 165 | Jerry Randall | www.venture-life.com |
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti.
Venture Life Group plc Fundamentals Summary
| VLG fundamental statistics | |
|---|---|
| Market cap | UK£49.33m |
| Earnings (TTM) | UK£921.00k |
| Revenue (TTM) | UK£51.41m |
53.6x
P/E Ratio1.0x
P/S RatioIs VLG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VLG income statement (TTM) | |
|---|---|
| Revenue | UK£51.41m |
| Cost of Revenue | UK£31.26m |
| Gross Profit | UK£20.15m |
| Other Expenses | UK£19.23m |
| Earnings | UK£921.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0073 |
| Gross Margin | 39.19% |
| Net Profit Margin | 1.79% |
| Debt/Equity Ratio | 25.3% |
How did VLG perform over the long term?
See historical performance and comparison